Cash Flow Statement

Amortization Amortization Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Working Capital Change in Working Capital Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued

Growth Metrics

Others

Amortization - Goodwill Cost of Revenue EBIAT Gross Profit Machine, Furnitures, Fixtures & Other Non-Current Receivables Other Gross PP&E Adjustments Other Gross PP&E Adjustments Receivables - Net Receivables - Other Rent Expense Shares Issued Shares Outstanding Shares Outstanding Wages, Salaries and Other

Avricore Health (AVCRF) Long-Term Debt Issuances (2020)

Avricore Health has reported Long-Term Debt Issuances over the past 1 years, most recently at $28848.2 for Q2 2020.

Quarterly Long-Term Debt Issuances changed N/A to $28848.2 in Q2 2020 from the year-ago period, while the trailing twelve-month figure was $700153.3 through Dec 2020, changed N/A year-over-year, with the annual reading at $701690.9 for FY2020, N/A changed from the prior year.
Long-Term Debt Issuances was $28848.2 for Q2 2020 at Avricore Health, down from $671305.1 in the prior quarter.
Over five years, Long-Term Debt Issuances peaked at $671305.1 in Q1 2020 and troughed at $28848.2 in Q2 2020.